Pathway Financial Advisors LLC Lantern Pharma Inc. Transaction History

Pathway Financial Advisors LLC

  • $379 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 10, 2024
SELL
$3.73 - $10.65 $13,055 - $37,275
-3,500 Reduced 12.28%
25,001 $220,000
Q4 2023

Jan 31, 2024
SELL
$2.48 - $4.39 $10,589 - $18,745
-4,270 Reduced 13.03%
28,501 $121,000
Q3 2023

Oct 30, 2023
BUY
$3.41 - $5.51 $64,005 - $103,422
18,770 Added 134.06%
32,771 $111,000
Q2 2023

Jul 18, 2023
BUY
$4.56 - $6.02 $63,844 - $84,286
14,001 New
14,001 $78,000

Others Institutions Holding LTRN

# of Institutions
34
Shares Held
1.31M
Call Options Held
39.8K
Put Options Held
6.1K
View Full List

About Lantern Pharma Inc.

LTRN Quotes by TradingView
  • Ticker LTRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,830,900
  • Market Cap $37M
  • Description
  • Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...
More about LTRN
Track This Portfolio

Track Pathway Financial Advisors LLC Portfolio

Follow Pathway Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathway Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathway Financial Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email